deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 1-arm NCT01680965

Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease

Ofatumumab in Combination With Glucocorticoids for Primary Therapy of Chronic Graft Versus Host Disease

Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Conditions Chronic Graft Versus Host Disease
Interventions Ofatumumab
Updated 21 times since 2017 Last updated: Sep 30, 2022 Started: Nov 14, 2012 Primary completion: Aug 31, 2020 Completion: Aug 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01680965, this PHASE1/PHASE2 trial focuses on Chronic Graft Versus Host Disease and remains completed. Sponsored by H. Lee Moffitt Cancer Center and Research Institute, it has been updated 21 times since 2012, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshot~Jun 2017 – ~Sep 2017 · 3 months · monthly snapshot~Sep 2017 – ~Jun 2018 · 9 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Dec 2018 · 5 months · monthly snapshot~Dec 2018 – ~May 2019 · 5 months · monthly snapshot~May 2019 – ~Aug 2019 · 3 months · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Nov 2019 · 31 days · monthly snapshot~Nov 2019 – ~Jan 2020 · 2 months · monthly snapshot~Jan 2020 – ~Dec 2020 · 11 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Dec 2021 · 3 months · monthly snapshot~Dec 2021 – ~May 2022 · 5 months · monthly snapshot~May 2022 – ~Nov 2022 · 6 months · monthly snapshot~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

21 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Nov 2022 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

    Status: Active Not Recruiting → Completed

  4. May 2022 — Nov 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  5. Dec 2021 — May 2022 [monthly]

    Active Not Recruiting PHASE1_PHASE2

▶ Show 16 earlier versions

  1. Sep 2021 — Dec 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  2. Feb 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  3. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  4. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  5. Jan 2020 — Dec 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  6. Nov 2019 — Jan 2020 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  7. Oct 2019 — Nov 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  8. Aug 2019 — Oct 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  9. May 2019 — Aug 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  10. Dec 2018 — May 2019 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  11. Jul 2018 — Dec 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  12. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

  13. Sep 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE1_PHASE2

    Status: Recruiting → Active Not Recruiting

  14. Jun 2017 — Sep 2017 [monthly]

    Recruiting PHASE1_PHASE2

  15. Feb 2017 — Jun 2017 [monthly]

    Recruiting PHASE1_PHASE2

  16. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE1_PHASE2

    First recorded

Nov 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • H. Lee Moffitt Cancer Center and Research Institute
Data source: H. Lee Moffitt Cancer Center and Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations